+

WO2002062974A3 - Regulation de la proteine humaine elongase hselo1 - Google Patents

Regulation de la proteine humaine elongase hselo1 Download PDF

Info

Publication number
WO2002062974A3
WO2002062974A3 PCT/EP2002/001262 EP0201262W WO02062974A3 WO 2002062974 A3 WO2002062974 A3 WO 2002062974A3 EP 0201262 W EP0201262 W EP 0201262W WO 02062974 A3 WO02062974 A3 WO 02062974A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
regulation
human elongase
hselo1
elongase hselo1
Prior art date
Application number
PCT/EP2002/001262
Other languages
English (en)
Other versions
WO2002062974A2 (fr
Inventor
Zhimin Zhu
Original Assignee
Bayer Ag
Zhimin Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Zhimin Zhu filed Critical Bayer Ag
Priority to AU2002247691A priority Critical patent/AU2002247691A1/en
Publication of WO2002062974A2 publication Critical patent/WO2002062974A2/fr
Publication of WO2002062974A3 publication Critical patent/WO2002062974A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des réactifs qui régulent la protéine humaine élongase de type HSELO1 et des réactifs qui se lient à des produits géniques de la protéine humaine élongase de type HSELO1. Ces réactifs peuvent jouer un rôle dans la prévention, l'amélioration ou la correction de dysfonctionnements ou de maladies dont, entre autres, le cancer, le diabète et des troubles du SNC.
PCT/EP2002/001262 2001-02-08 2002-02-07 Regulation de la proteine humaine elongase hselo1 WO2002062974A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002247691A AU2002247691A1 (en) 2001-02-08 2002-02-07 Regulation of human elongase hselo1-like protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26713501P 2001-02-08 2001-02-08
US60/267,135 2001-02-08

Publications (2)

Publication Number Publication Date
WO2002062974A2 WO2002062974A2 (fr) 2002-08-15
WO2002062974A3 true WO2002062974A3 (fr) 2003-02-20

Family

ID=23017464

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/001262 WO2002062974A2 (fr) 2001-02-08 2002-02-07 Regulation de la proteine humaine elongase hselo1

Country Status (2)

Country Link
AU (1) AU2002247691A1 (fr)
WO (1) WO2002062974A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004532638A (ja) * 2001-06-05 2004-10-28 エクセリクシス・インコーポレイテッド ｐ５３経路のモディファイヤーとしてのＭＡＰ３Ｋｓおよび使用方法
US20060189518A1 (en) * 2002-06-26 2006-08-24 Takeda Pharmaceutical Company Limited Preventing/remedies for cancer
WO2005030985A2 (fr) * 2003-09-25 2005-04-07 Devgen N.V. Utilisation de sequences d'acides amines impliquees dans l'elongation d'acides gras lors de l'identification et/ou du developpement de composes destines a prevenir et/ou a traiter des maladies metaboliques

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000070945A2 (fr) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Genes impliques dans l'allongement des chaines d'acides gras et utilisations associees
WO2001034643A1 (fr) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 24 proteines humaines secretees
WO2002044320A2 (fr) * 2000-11-29 2002-06-06 Xenon Genetics Inc. Genes humains de l'elongase, leurs utilisations et composes destines a leur modulation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000070945A2 (fr) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Genes impliques dans l'allongement des chaines d'acides gras et utilisations associees
WO2001034643A1 (fr) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 24 proteines humaines secretees
WO2002044320A2 (fr) * 2000-11-29 2002-06-06 Xenon Genetics Inc. Genes humains de l'elongase, leurs utilisations et composes destines a leur modulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PARKER-BARNES JENNIFER M ET AL: "Identification and characterization of an enzyme involved in the elongation of n-6 and n-3 polyunsaturated fatty acids", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 97, no. 15, 18 July 2000 (2000-07-18), pages 8284 - 8289, XP002200200, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2002062974A2 (fr) 2002-08-15
AU2002247691A1 (en) 2002-08-19

Similar Documents

Publication Publication Date Title
WO2002020731A3 (fr) Regulation de l'enzyme humaine du type proteine disulfide isomerase
WO2002072824A3 (fr) Regulation du canal potentiel humain du recepteur transitoire humain
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2002062975A3 (fr) Regulation de la proteine humaine du type elongase hselo1
WO2002081705A3 (fr) Regulation de la proteine humaine de type acetyltransferase gnat
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2002088362A3 (fr) Regulation d'une proteine semblable a la prostaglandine-f synthase 1 humaine
WO2003033708A3 (fr) Regulation de la proteine kinase humaine a serine/threonine
WO2002055712A3 (fr) Regulation de l'alanine aminotransferase humaine
WO2003052088A3 (fr) Regulation de la sialyltransferase humaine
WO2002057461A3 (fr) Regulation de la metalloprotease a zinc de type adam-ts humaine
WO2003033709A3 (fr) Regulation de la proteine kinase serine/threonine humaine
WO2002072825A3 (fr) Regulation de la proteine humaine de type mrp5
WO2002033080A3 (fr) Regulation du recepteur humain membranaire liant la netrine unc5h-1
WO2002046403A3 (fr) Regulation de la proteine humaine du type 'patched'
WO2003025174A3 (fr) Regulation de la proteine humaine de type mrp1
WO2002055710A3 (fr) Regulation de l'acide phosphatase pourpre humain
WO2002081666A3 (fr) Regulation de la proteine humaine de type phosphatase
WO2002081706A3 (fr) Regulation d'une proteine de type phosphatase humaine
WO2003000903A3 (fr) Regulation de serine/threonine proteine kinase humaine de type nek
WO2002092798A3 (fr) Regulation d'une proteine humaine de type 2c de phosphatase acide phosphatidique
WO2002081704A3 (fr) Regulation de la proteine de type proteine kinase humaine
WO2003035862A3 (fr) Regulation d'une proteine contenant une signature d'arginase humaine
WO2002033056A3 (fr) Regulation de serine-threonine kinase humaine
WO2003016515A3 (fr) Regulation de la proteine humaine de type glycerol-3-phosphate acyltransferase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载